| # | Country | Total Patents | |
|---|---|---|---|
| #1 | China | 6 | |
| #2 | EPO (European Patent Office) | 6 | |
| #3 | United States | 5 | |
| #4 | WIPO (World Intellectual Property Organization) | 5 | |
| #5 | Australia | 3 | |
| #6 | Canada | 2 | |
| #7 | Republic of Korea | 2 | |
| #8 | Singapore | 2 | |
| #9 | Hong Kong | 1 | |
| #10 | Hungary | 1 | |
| #11 | Japan | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Measurement | |
| #3 | Biotechnology |
| # | Technology | |
|---|---|---|
| #1 | Analysing materials | |
| #2 | Peptides | |
| #3 | Therapeutic chemical compounds | |
| #4 | Medical preparations |
| # | Name | Total Patents |
|---|---|---|
| #1 | Yokoseki Tatsuki | 28 |
| #2 | Matsubara Etsuro | 22 |
| #3 | Shibata Masao | 22 |
| #4 | Ito Toshiyuki | 7 |
| #5 | Okamoto Yasuhide | 7 |
| #6 | Fujii Shinobu | 7 |
| #7 | Takamatsu Naofumi | 7 |
| #8 | Imai Yukiho | 7 |
| #9 | Umeda Makoto | 7 |
| #10 | Tatsuki Yokoseki | 4 |
| Publication | Filing date | Title |
|---|---|---|
| CN102574915A | Antibodies that specifically bind to A beta oligomers and use thereof | |
| EP2462162A1 | Antibodies that specifically bind to a beta oligomers and use thereof | |
| EP2419447A1 | Antibodies that specifically bind to a beta oligomers and use thereof | |
| US2010291071A1 | Antibody Specific Binding to A-Beta Oligomer and the Use | |
| KR20100113623A | ANTIBODY CAPABLE OF BINDING SPECIFICALLY TO Aβ-OLIGOMER, AND USE THEREOF | |
| AU2008312802A1 | Antibody capable of specifically binding to abeta oligomer, and use thereof |